The National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security (MoHRSS) have jointly issued China's first-ever innovative drug catalogue designed specifically for commercial health insurance. One objective is to unlock new growth opportunities for the commercial health insurance market.